SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity

J Infect. 2023 Oct;87(4):346-349. doi: 10.1016/j.jinf.2023.05.023. Epub 2023 Jun 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Patient Acuity
  • SARS-CoV-2
  • T-Lymphocytes

Substances

  • Antibodies, Viral